Alto Neuroscience, Inc. (ANRO) income statement
ANRONYSEPharmaceutical PreparationsFiscal year ends December 31
$25.37−1.14 (-4.30%)
Close on Nov 20, 2026Market cap $995.57MP/E –Yield –
Alto Neuroscience, Inc. financial ratios
See a number that looks wrong?